A study in head and neck cancer cells demonstrated that ADAM12 increased HER2 expression, HER2 inhibition decreased ADAM12 expression, and HER2 transfection increased ADAM12 expression suggesting there is a positive feedback loop between those two65. This evidence concerns the gene ADAM12 and head and neck cancer.